ESMO22: Glenn Hanna, MD | Dana-Farber Cancer Institute

(1:43)

ESMO22: Breast cancer research by Sara Tolaney, MD (TROPiCS) | Dana-Farber Cancer Institute

(1:18)

ASCO23: Glenn Hanna, MD | Dana-Farber Cancer Institute

(1:41)

Case Study: Identifying Molecular Residual Disease - Dr. Glenn Hanna

(2:50)

Clinical Application of NavDx in the Surveillance Setting (5min) - Dr. Glenn Hanna

(5:13)

Seminar Clips: Diversity in Clinical Trials- Robert A. Winn, MD | Stanford Cancer Institute

(1:14)

Case Study: Early Identification of Recurrence in Surveillance - Dr. Glenn Hanna

(1:41)

Upcoming GU cancer trials to be presented at ESMO 2022

(1:20)

Upcoming updates in GU cancers at ESMO 2022

(55)

INUS Neuro-Urology News - Interview with the Expert: Rose Khavari

(23:3)

Research Is the Reason I Can Better Treat My Patients

(1:56)

New Approaches to Blood Pressure Measurement and Control

(10:1econd)

Envita Medical Centers offers a cancer treatment

(3:51)

Living Your Best Life as a Brain Tumor Patient and Caregiver

(58:35)

Lymphoma highlights at ASCO 2022

(1:19)

IGF Chair Glenn Gemerts closing remarks at IGF's 2017 AGM

(57)